It is also speculated that during cardiovascular disease, AT2R upregulation and activation by Ang II, or angiotensin peptide fragments (i.e., Ang III, Ang IV, and/or Ang 1–7) may limit AT1R-mediated overactivity and cardiovascular pathologies [13, 14]. The gene discussed is AGT; the disease is cardiovascular disorder.